AMLX short interest
Amylyx Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 12,666,971 |
|---|---|
| Change vs prior report | -845,782 (-6.3%) |
| Change over six months | -11.0% |
| Days to cover | 9.16 (sector: 3.78) |
| Average daily volume | 1,382,131 |
| Rank in Healthcare | #141 of 922 by days to cover |
AMLX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 12,666,971 | -6.3% | 9.16 | 1,382,131 |
| 2026-09-15 | 13,512,753 | +6.1% | 8.64 | 1,563,524 |
| 2026-08-31 | 12,737,201 | -5.1% | 2.37 | 5,379,256 |
| 2026-08-14 | 13,425,106 | +0.2% | 7.14 | 1,881,057 |
| 2026-07-31 | 13,401,722 | +9.3% | 6.84 | 1,959,109 |
| 2026-07-15 | 12,265,993 | -14.7% | 9.21 | 1,332,522 |
| 2026-06-30 | 14,385,180 | +9.6% | 7.06 | 2,038,056 |
| 2026-06-15 | 13,121,697 | -12.3% | 8.12 | 1,616,733 |
| 2026-05-29 | 14,957,523 | +3.0% | 16.33 | 916,139 |
| 2026-05-15 | 14,514,401 | -1.9% | 12.16 | 1,193,178 |
| 2026-04-30 | 14,800,969 | -0.2% | 14.26 | 1,037,735 |
| 2026-04-15 | 14,831,510 | +4.2% | 12.23 | 1,212,978 |
| 2026-03-31 | 14,231,261 | +2.6% | 14.14 | 1,006,491 |
| 2026-03-13 | 13,864,210 | -4.4% | 12.49 | 1,110,465 |
| 2026-02-27 | 14,497,298 | +1.3% | 19.07 | 760,335 |
| 2026-02-13 | 14,310,589 | +4.1% | 17.43 | 820,962 |
| 2026-01-30 | 13,752,736 | +2.4% | 6.59 | 2,088,336 |
| 2026-01-15 | 13,437,426 | -1.5% | 7.70 | 1,744,583 |
| 2025-12-31 | 13,642,380 | +13.0% | 7.51 | 1,816,629 |
| 2025-12-15 | 12,068,995 | +3.8% | 10.90 | 1,107,605 |
| 2025-11-28 | 11,623,612 | -2.4% | 8.31 | 1,399,419 |
| 2025-11-14 | 11,911,669 | +14.0% | 7.48 | 1,591,901 |
| 2025-10-31 | 10,449,446 | +8.7% | 6.85 | 1,525,945 |
| 2025-10-15 | 9,616,175 | -4.5% | 5.01 | 1,918,584 |
| 2025-09-30 | 10,066,534 | +14.7% | 5.09 | 1,976,363 |
import finzdata as yf
yf.Ticker("AMLX").short_interest # every report since 2017
yf.Client().short_interest(["AMLX"], start="2018-01-01")Healthcare short interest · AMLX price history · Who owns AMLX · All short interest